Literature DB >> 206643

Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis.

M A Alspaugh, F C Jensen, H Rabin, E M Tan.   

Abstract

Sera from approximately two-thirds of patients with rheumatoid arthritis contain an antibody which is reactive with a nuclear antigen present in human B-lymphocyte tissue culture cells. The immunological reaction can be demonstrated by precipitation and immunofluorescence. Evidence is present that the reactive nuclear antigen is associated with Epstein-Barr (EB) virus-transformed lymphocytes. Normal human peripheral blood lymphocytes did not contain the nuclear antigen reactive with rheumatoid arthritis sera, but after infection with EB virus, they showed increasing amounts of reactive nuclear antigen as the cells were transformed into continuous lines. Several established human and simian lymphocyte cell lines known to carry EB viral genomes were shown to contain rheumatoid arthritis-associated nuclear antigen. Evidence is presented which suggests that the rheumatoid arthritis-associated nuclear antigen is different from the previously described EB nuclear antigen.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206643      PMCID: PMC2184239          DOI: 10.1084/jem.147.4.1018

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

Review 1.  RHEUMATOID ARTHRITIS.

Authors:  H G KUNKEL; R C WILLIAMS
Journal:  Annu Rev Med       Date:  1964       Impact factor: 13.739

Review 2.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

3.  Lymphoid cell-culture line derived from lymph node of marmoset infected wtih Herpesvirus saimiri--preliminary report.

Authors:  A S Rabson; G T O'Conor; D E Lorenz; R L Kirschstein; F Y Legallais; T S Tralka
Journal:  J Natl Cancer Inst       Date:  1971-05       Impact factor: 13.506

4.  Immunofluorescent localization of the third and the fourth component of complement in synovial tissue from patients with rheumatoid arthritis.

Authors:  W S Rodman; R C Williams; P J Bilka; H J Müller-Eberhard
Journal:  J Lab Clin Med       Date:  1967-01

5.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Virologic studies on rheumatoid arthritis.

Authors:  R M Wilkes; J P Simsarian; H E Hopps; H Roth; J L Decker; R G Aptekar; H M Meyer
Journal:  Arthritis Rheum       Date:  1973 Jul-Aug

7.  A search for viruses and mycoplasms in connective tissue diseases.

Authors:  D A Person; J T Sharp; W E Rawls
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

8.  Occurrence of -globulin complexes in serum and joint fluid of rheumatoid arthritis patients: use of monoclonal rheumatoid factors as reagents for their demonstration.

Authors:  R J Winchester; H G Kunkel; V Agnello
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

9.  Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.

Authors:  K O Fresen; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

10.  Mononuclear cells in human synovial fluid. Identification of lymphoblasts in rheumatoid arthritis.

Authors:  R B Traycoff; E Pascual; H R Schumacher
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug
View more
  53 in total

1.  Antibodies to Epstein-Barr viral antigens in familial rheumatoid arthritis.

Authors:  M McDermott; M Molloy; J Buckley; J Greally
Journal:  Ir J Med Sci       Date:  1989-08       Impact factor: 1.568

2.  Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. ii. Mechanisms of non-permissiveness.

Authors:  D J Appleford; A M Denman
Journal:  Ann Rheum Dis       Date:  1979-10       Impact factor: 19.103

3.  Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women.

Authors:  Barbara L Goldstein; Lori B Chibnik; Elizabeth W Karlson; Karen H Costenbader
Journal:  Autoimmunity       Date:  2011-10-20       Impact factor: 2.815

Review 4.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

5.  B-lymphocyte activation with an extract of Nocardia brasiliensis.

Authors:  L Ortiz-Oritz; D E Parks; J S Lopez; W O Weigle
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

6.  Spontaneous cytotoxicity of rheumatoid and normal peripheral blood mononuclear cells against 4 human lymphoblastoid cell lines.

Authors:  J Highton; G S Panayi
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

7.  Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.

Authors:  G Tosato; A D Steinberg; R Yarchoan; C A Heilman; S E Pike; V De Seau; R M Blaese
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

8.  Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis.

Authors:  M A Alspaugh; G Henle; E T Lennette; W Henle
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

9.  Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis.

Authors:  P B Ferrell; C T Aitcheson; G R Pearson; E M Tan
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

10.  Epstein-Barr-Virus-Infected CD15 (Lewis X)-Positive Hodgkin-Lymphoma-Like B Cells in Patients with Rheumatoid Arthritis.

Authors:  Hirotake Inomata; Masami Takei; Hiroyuki Nakamura; Shigeyoshi Fujiwara; Hidetaka Shiraiwa; Noboru Kitamura; Shunsei Hirohata; Hiroyuki Masuda; Jin Takeuchi; Shigemasa Sawada
Journal:  Open Rheumatol J       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.